Back to overview

Kathrin Schneider, Head of Business Development EU and APAC (ext.)

Kathrin Schneider is an experienced commercialization executive bringing more than a decade of experience in the life science sector, with a strong focus on cell and gene therapy. She has held multiple senior commercial leadership roles and has a proven track record of building and leading high-performing global commercial teams.

Prior to joining DINAMIQS, Kathrin spent 13 years with SIRION Biotech, now part of Revvity Inc., most recently serving as Senior Vice President, Global Business. During her tenure, she played a pivotal role in transforming the start-up into a profitable worldwide leader in viral vector technologies for cell and gene therapy culminating in a successful exit. In addition, she serves as an independent strategic advisor to life science organizations, supporting commercial operations as well corporate strategy. 

With a strong scientific foundation combined with deep commercial acumen, Kathrin is passionate about implementing structures and strategies that enable sustainable, long-term growth. She holds a PhD and a diploma in Molecular Biology and Biomedical Sciences from the Universities of Marburg and Würzburg. Kathrin is a German citizen. 

To top